COPD
Conditions
Interventions
Maintenance therapy in accordance with Japanese COPD guideline
Sponsors
Tokyo Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnosis of COPD by respiratory specialist. Not receiving of maintenance therapy with LABA, LAMA and ICS Patients who are judged to be included in the study by investigator based on a preliminary clinical examination. Written Informed Consent Form prior to participation in the trial.
Exclusion criteria
Exclusion criteria: A known hypersensitivity to the components of each standard drug for COPD. Known diseases which contraindicate using the standard drugs for COPD according to the package insert. Patients who are judged not to be included in the study by investigator based on a preliminary clinical examination. Not able to follow an instruction for a smoking cessation. A history of asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, or pulmonary thromboembolic disease. Not able to perform pulmonary function tests. Participation in another trial with an investigational drug within 2 month prior to informed consent visit. Pregnant or nursing women or women of childbearing potential who are not using a medically approved means of contraception.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of pulmonary function (trough FEV1 and trough FVC) | — |
Countries
Japan
Contacts
Public ContactYasuhiro Setoguchi
Tokyo Medical University Hospital Respiratory Medicine
Outcome results
None listed